Associated Press/AP Online
By MARILYNN MARCHIONE
BOSTON - A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.
Boston scientists who invented the test and health care giant Johnson & Johnson will announce Monday that they are joining forces to bring it to market. Four big cancer centers also will start studies using the experimental test this year.
Stray cancer cells in the blood mean that a tumor has spread or is likely to, many doctors believe. A test that can capture such cells has the potential to transform care for many types of cancer, especially breast, prostate, colon and lung.
Initially, doctors want to use the test to try to predict what treatments would be best for each patient's tumor and find out quickly if they are working.
That's funny, I had that test done three years ago.
Hey, maybe next year we're going to invent a chemotherapy sensitivity test... Oh, wait a minute, I had that done three years ago too.
Great news, Brett. I knew this was going to be a good year! God bless!
ReplyDeleteGASP! ~ He speaks
ReplyDeleteYou've always been a pioneer Brett ~lol~
Keep gaining and keep posting ~ we miss you
S~xoxo
Hey Brett,
ReplyDeleteIt’s always great to hear that you continue to do so well. I think this is just proof that we need you to help other patients realize that their future really does lie in their own hands and that they must have the final say in their healthcare. Happy Birthday!! (Okay…I know I’m more than a few days early, but I wanted to make sure to get it in!!)
God Bless you!
Great! I appreciate your efforts in sharing this informative and useful story. I would love to share this to my alternative cancer treatments center. Thanks a lot and have a nice day!
ReplyDelete